FIELD: medicine.
SUBSTANCE: there are offered: IL-6 receptor antibody, a coding gene, a vector and a host cell for producing the antibody, a method for producing the antibodies, and a pharmaceutical composition for treating IL-6-related diseases containing the antibody.
EFFECT: use of the invention provides new humanised IL-6 receptor antibodies that can find further application in therapy of the IL-6-mediated diseases.
8 cl, 22 dwg, 8 tbl, 9 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL FORMULATION CONTAINING ADVANCED ANTIBODY MOLECULES | 2010 |
|
RU2565809C2 |
MODIFIED CONSTANT REGION OF ANTIBODY | 2008 |
|
RU2526512C2 |
MODIFIED ANTIBODY CONSTANT REGION | 2021 |
|
RU2797273C2 |
MEDICATION FOR TREATMENT OF RHEUMATOID ARTHRITIS | 2010 |
|
RU2524152C2 |
ANTIGEN-BINDING MOLECULE CAPABLE OF REPEATEDLY BINDING TWO OR MORE ANTIGEN MOLECULES | 2009 |
|
RU2571225C2 |
ANTIGEN-BINDING MOLECULE CAPABLE OF MULTIPLE BINDING OF TWO OR MORE ANTIGEN MOLECULES | 2014 |
|
RU2756029C2 |
ANTIBODIES PRIMARILY BINDING TO EXTRACELLULAR DOMAIN 4 OF HUMAN CSF-1R, AND USING THEM | 2010 |
|
RU2565541C2 |
ANTIBODIES AGAINST HUMAN IL33R AND USE THEREOF | 2012 |
|
RU2597288C2 |
CYTOTOXICITY-INDUCING THERAPEUTIC AGENT | 2015 |
|
RU2812875C1 |
NR10 ANTIBODY AND USING IT | 2008 |
|
RU2531521C2 |
Authors
Dates
2011-09-27—Published
2009-09-25—Filed